Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


2012 Scrip 100: Successful trial outcomes – peering into the crystal ball

This article was originally published in Scrip

Executive Summary

With rising trial costs and shrinking budgets, pharma companies are working more diligently than ever to identify keys to success in the clinic. But without the benefit of the proverbial crystal ball, the industry must rely on examining historical records as predictors or benchmarks of future performance. Susan Danheiser and the Citeline Analytics team begin to explore this notion, and outline key findings from a retrospective analysis of clinical trial outcomes in six therapeutic areas.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts